Version 2.78

Description

Doripenem is an ultra-broad spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005, and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa.

Doripenem was approved by the United States Food and Drug Administration on October 12, 2007, to be sold under the tradename Doribax. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Doripenem

Basic Part Properties

Part Display Name
Doripenem
Part Type
Component (Describes the core component or analyte measured)
Created On
2009-07-06
Construct for LOINC Short Name
Doripenem

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP95252-0
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP95252-0

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 多尼培南
Synonyms: 多利培南;抗生素类药; 碳青霉烯类抗生素
fr-CA French (Canada) Doripénème
et-EE Estonian (Estonia) Doripeneem
es-ES Spanish (Spain) Doripenem
it-IT Italian (Italy) Doripenem
tr-TR Turkish (Turkey) Doripenem
ru-RU Russian (Russian Federation) Дорипенем
nl-NL Dutch (Netherlands) doripenem
fr-BE French (Belgium) Doripenem